ketanserin has been researched along with Oliguria in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Oliguria: Decreased URINE output that is below the normal range. Oliguria can be defined as urine output of less than or equal to 0.5 or 1 ml/kg/hr depending on the age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ketanserin is an attractive alternative in the management of severe early-onset preeclampsia." | 6.69 | Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome. ( Bolte, AC; Bruinse, HW; Dekker, GA; Kanhai, HH; van Eyck, J; van Geijn, HP, 1999) |
| "Ketanserin is an attractive alternative in the management of severe early-onset preeclampsia." | 2.69 | Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome. ( Bolte, AC; Bruinse, HW; Dekker, GA; Kanhai, HH; van Eyck, J; van Geijn, HP, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolte, AC | 1 |
| van Eyck, J | 1 |
| Kanhai, HH | 1 |
| Bruinse, HW | 1 |
| van Geijn, HP | 1 |
| Dekker, GA | 1 |
1 trial available for ketanserin and Oliguria
| Article | Year |
|---|---|
Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Dihydralazine; Female; HELLP Syndrome; Humans; Ketan | 1999 |